A positive surprise is on the way: Spyre Therapeutics Inc. (SYRE) Stock
Wells Fargo raised the price target for the Spyre Therapeutics Inc. (NASDAQ:SYRE) stock from “an Equal weight” to “an Overweight”. The rating was released on March 01, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $31. The stock was initiated by Guggenheim, […]
What does the future hold for Spyre Therapeutics Inc. (SYRE) Stock?
Wells Fargo raised the price target for the Spyre Therapeutics Inc. (NASDAQ:SYRE) stock from “an Equal weight” to “an Overweight”. The rating was released on March 01, 2024, according to finviz. The research report from Jefferies has initiated the stock to Buy, with a price target set at $31. The stock was initiated by Guggenheim, […]
